Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$141.76

0.37 (0.26%)

06:05
12/17/19
12/17
06:05
12/17/19
06:05

Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst David Lewis upgraded Johnson & Johnson to Overweight from Equal Weight with a $170 price target.

  • 19

    Dec

  • 22

    Jan

JNJ Johnson & Johnson
$141.76

0.37 (0.26%)

12/08/19
PIPR
12/08/19
NO CHANGE
PIPR
Piper says Bluebird's bb2121 'clearly approvable,' but competition heating up
Piper Jaffray analyst Tyler Van Buren said the topline results presented by Bluebird Bio (BLUE) at ASH from the KarMMa trial are "impressive in these very sick patients" and he believes that the drug is "clearly approvable." However, he also said that the JNJ-4528 Legend data presented by Johnson & Johnson's (JNJ) Janssen "appears very competitive," adding that "we would be remiss if we didn't mention the continued deluge of anti-BCMA antibody data" from competitors including Amgen (AMGN), Bristol-Myers (BMY) and Regeneron (REGN). Van Buren keeps a Neutral rating on Bluebird Bio shares, citing valuation as well as his view on long-term competitive pressures.
12/08/19
PIPR
12/08/19
NO CHANGE
Target $177
PIPR
Overweight
Argenx data on cusatuzumab 'continues to impress,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff said Argenx (ARGX) "continues to impress" with the Phase I data on cusatuzumab in combination with azacitidine in newly diagnosed AML patients presented at the ASH meeting this weekend. Argenx has received the first $25M milestone of up to $1.3B it is eligible for under Janssen (JNJ) licensing agreement, noted Tenthoff, who added that argenx retains a 50/50 U.S. profit share on the drug. He reiterated his Overweight rating and $177 price target on Argenx shares following the medical meeting.
12/09/19
STFL
12/09/19
NO CHANGE
Target $96
STFL
Hold
Bluebird Bio share rebound potential dampened by JNJ-4528 news, says Stifel
Stifel analyst Benjamin Burnett said the bb2121 KarMMa data reported by Bluebird Bio (BLUE) "looks approvable" and likely will lead to Bluebird having a first mover advantage in multiple myeloma. However, although he sees Bluebird as "clearly ahead of competitors," he thinks it will be tough for the stock to appreciate beyond a small rebound given there are "so many me-too programs advancing behind them," including Janssen's (JNJ) JNJ-4528, which generated "high ORR." Burnett, who keeps a Hold rating and $96 price target on Bluebird shares, added that LentiGlobin continues to look impressive in sickle cell disease, but that disease area "has become a hotbed for gene therapy/gene editing development."
12/11/19
PIPR
12/11/19
NO CHANGE
Target $28
PIPR
Overweight
XBiotech price target raised to $28 from $16 at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro raised his price target for XBiotech (XBIT) to $28 from $16 after fully incorporating the sale of bermekimab to Johnson & Johnson (JNJ) into his model. XBiotech now has "runway sufficient" to fully explore the role of IL-1alpha across numerous non-derm indications as well as its True Human Antibody discovery platform, Catanzaro tells investors in a research note. He keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ENV

Envestnet

$70.39

-4.05 (-5.44%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Hot Stocks
Lawmakers urge FTC to investigate Envestnet over sale of financial data »

Several U.S. lawmakers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SNCA

Seneca Biopharma

$3.80

2.55 (204.00%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Syndicate
Seneca Biopharma announces exercise of warrants for $7.55M gross proceeds »

Seneca Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHT

DHT Holdings

$7.41

0.19 (2.63%)

14:05
01/17/20
01/17
14:05
01/17/20
14:05
Options
DHT Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
01/17/20
01/17
14:05
01/17/20
14:05
General news
Action Economics Survey results: »

Action Economics Survey…

BGNE

BeiGene

$169.60

1.72 (1.02%)

14:03
01/17/20
01/17
14:03
01/17/20
14:03
Upgrade
BeiGene rating change  »

BeiGene upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SNE

Sony

$72.46

-0.09 (-0.12%)

, CMCSA

Comcast

$47.43

0.57 (1.22%)

13:57
01/17/20
01/17
13:57
01/17/20
13:57
On The Fly
Box Office Battle: 'Bad Boys for Life' opens strong »

Welcome to "Box Office…

SNE

Sony

$72.46

-0.09 (-0.12%)

CMCSA

Comcast

$47.43

0.57 (1.22%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$38.33

0.3 (0.79%)

DIS

Disney

$144.67

-0.43 (-0.30%)

LGF.A

Lionsgate

$10.94

-0.34 (-3.01%)

LGF.B

Lionsgate

$10.30

-0.325 (-3.06%)

VIAC

ViacomCBS

$39.64

-0.41 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 04

    Feb

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

BA

Boeing

$325.18

-6.82 (-2.05%)

13:46
01/17/20
01/17
13:46
01/17/20
13:46
Periodicals
Boeing tells CNBC 'making necessary updates' to MAX after report of new issue »

After ABC's David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$326.24

-5.76 (-1.73%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing down 2% to $325.88…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

, IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

TLT

iShares 20+ Year Treasury Bond Fund

$138.05

-1.15 (-0.83%)

ESGU

iShares ESG MSCI U.S.A. ETF

$73.74

0.27 (0.37%)

VCSH

Vanguard Short-Term Corporate Bond Index Fund

$81.21

0.025 (0.03%)

SPY

SPDR S&P 500 ETF Trust

$331.63

0.73 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$326.27

-5.73 (-1.73%)

13:42
01/17/20
01/17
13:42
01/17/20
13:42
Periodicals
ABC learns of another software issue with Boeing 737 Max »

ABC's David Kerley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JNJ

Johnson & Johnson

$148.97

0.72 (0.49%)

13:39
01/17/20
01/17
13:39
01/17/20
13:39
Periodicals
Judge slashes J&J verdict down to $6.8M from $8B in Risperdal suit, Law.com says »

Philadelphia Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

JNJ

Johnson & Johnson

$149.03

0.78 (0.53%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Periodicals
Judge cuts J&J punishment in Risperdal case to $6.8M from $8B, Bloomberg reports »

On October 8, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/17/20
01/17
13:16
01/17/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$23.56

0.06 (0.26%)

13:04
01/17/20
01/17
13:04
01/17/20
13:04
Hot Stocks
Baker Hughes reports U.S. rig count up 15 to 796 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

MDR

McDermott

$0.73

0.0119 (1.66%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Hot Stocks
McDermott announces start of commercial operation of Freeport LNG Train 2 »

McDermott International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$240.69

0.17 (0.07%)

13:02
01/17/20
01/17
13:02
01/17/20
13:02
Recommendations
Amgen analyst commentary  »

Amgen raised prices today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BKR

Baker Hughes

$23.57

0.07 (0.30%)

13:01
01/17/20
01/17
13:01
01/17/20
13:01
Hot Stocks
Breaking Hot Stocks news story on Baker Hughes »

Baker Hughes reports U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

SNCA

Seneca Biopharma

$3.09

1.84 (147.20%)

12:59
01/17/20
01/17
12:59
01/17/20
12:59
Hot Stocks
Seneca Biopharma surges after saying talks starting with 'interested parties' »

Shares of micro-cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$20.02

0.19 (0.96%)

12:45
01/17/20
01/17
12:45
01/17/20
12:45
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

12:45
01/17/20
01/17
12:45
01/17/20
12:45
General news
Breaking General news story  »

Week of 1/17 Baker-Hughes…

DLAKY

Lufthansa

$0.00

(0.00%)

12:41
01/17/20
01/17
12:41
01/17/20
12:41
Periodicals
Lufthansa extends Tehran flight halt until March 28, Reuters reports »

Lufthansa said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:36
01/17/20
01/17
12:36
01/17/20
12:36
Hot Stocks
Toyota provides outline of production alignment through 2022 »

To "improve the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$139.71

-0.32 (-0.23%)

12:33
01/17/20
01/17
12:33
01/17/20
12:33
Hot Stocks
Toyota Indiana completes $1.3B modernization, adds 550 new jobs »

Toyota Indiana invested…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.